Intratumoral and peritumoral radiomics of MRI predicts pathologic complete response to neoadjuvant chemoimmunotherapy in patients with head and neck squamous cell carcinoma

J Immunother Cancer. 2025 Jan 6;13(1):e011189. doi: 10.1136/jitc-2024-011189.
No abstract available

Keywords: Biomarker; Neoadjuvant.

Publication types

  • Letter